BDMD (Baird Medical Investment Holdings) Total Stockholders Equity : $39.25 Mil (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Total Stockholders Equity?

Baird Medical Investment Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2024 was $39.25 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Baird Medical Investment Holdings's Book Value per Share for the quarter that ended in Jun. 2024 was $1.11. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Baird Medical Investment Holdings's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.40.

Baird Medical Investment Holdings Total Stockholders Equity Historical Data

The historical data trend for Baird Medical Investment Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Total Stockholders Equity Chart

Baird Medical Investment Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Total Stockholders Equity

15.38

25.93

35.75

Baird Medical Investment Holdings Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24
Total Stockholders Equity	15.38	25.93	-	35.75	39.25

Baird Medical Investment Holdings (NAS:BDMD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Baird Medical Investment Holdings's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(39.252	-	0)	/	35.450
	=	1.11

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Baird Medical Investment Holdings's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(14.166	+	1.351)	/	39.252
	=	0.40

Baird Medical Investment Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Baird Medical Investment Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN

Website

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.